openPR Logo
Press release

North America and Europe PEGylated Drugs Market Forecast Analysis with Key Players: Merck, Shire Group, Amgen, UCB, AstraZeneca, Sigma Tau, Pfizer, Roche, and Biogen

10-22-2018 04:37 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

North America and Europe PEGylated Drugs Market

North America and Europe PEGylated Drugs Market

The North America and Europe PEGylated Drugs Market size is set to exceed USD 10.5 billion by 2024; according to a new research report by Global Market Insights.

Key Players:

Merck KGaA
Biogen Inc.
AstraZeneca
UCB
Amgen
Sigma Tau (Leadiant Biosciences)
Roche
Shire Group
Pfizer
Novo Nordisk

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2511

Increasing R&D investment of biotechnology & pharmaceutical companies to develop enhanced PEGylated drugs for treatment of various chronic diseases along with rising occurrence of chronic ailments in developed regions will propel PEGylated drugs market growth over the forecast period.

Major advancements in biologics sector including advances in drug antibody conjugates, and immunotherapies will positively impact market growth. Moreover, rising incidences of chronic ailments and increasing death rates associated with cancer in Canada will propel industry growth. However, the side-effects associated with pegylated drugs along with drug failure will impede PEGylated drugs market growth over the forecast timeframe.

Cancer segment held over 60% of the overall market share in 2017 due to growing prevalence of the disease creating a demand for the development of effective drugs. Benefits offered by PEGylated drugs such as reduced proteolytic degradation along with minimized immunogenicity leading to enhanced therapeutic efficacy will propel market growth. Increasing areas of applications as well as rising adoption of PEGylated drugs to treat various types of cancer will stimulate business growth.

Hepatitis segment size was USD 156 million in 2017 and is anticipated to follow a declining trend over the forecast period. However, increasing focus of industry players to develop pegylated drugs used for the treatment of such chronic conditions will contribute to market growth. For instance, launch of Pegasys drug used for treating Hepatitis C in adult patients will fuel market growth.

Monoclonal antibodies are anticipated to witness over 12% CAGR over the coming years due to its wide-ranging applications such as, anti-PEG antibodies are used to quantitate numerous PEGylated compounds. Additionally, anti-PEG antibodies can be combined with compound specific to antibody to generate specific and sensitive assays.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2511

Canada PEGylated drugs market will witness over 5.5% CAGR from 2018 to 2024. Increasing prevalence of chronic ailments such as cancer will drive the business growth. As per Canadian Cancer Society, more than two lac people are diagnosed with cancer in 2017 that will surge demand for pegylated drugs in the future. Development and availability of various pegylated drugs including Onivyde, Plegridy, Oncaspar and others for treatment of several chronic ailments are factors accelerating business growth over the forecast timeframe.

Italy PEGylated drugs market was USD 218 million in 2017 and is anticipated to witness 9% CAGR over the coming few years. Increasing usage of peg-interferons for the treatment of Hepatitis C and soaring adoption of PEG-IFN beta-1a injectables for the treatment of patients with multiple sclerosis will foster market growth.

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America and Europe PEGylated Drugs Market Forecast Analysis with Key Players: Merck, Shire Group, Amgen, UCB, AstraZeneca, Sigma Tau, Pfizer, Roche, and Biogen here

News-ID: 1319347 • Views: 332

More Releases from Global Market Insights, Inc.

Recycled elastomers market trends analysis, growth, Size, forecasts with top key …
As pr estimates that global recycled elastomers market size will be worth more than US$6 billion by 2025. The industry share is classified on the basis of raw material, application and region. The raw material segment is further segmented into natural rubber, chloroprene rubber, polyurethane rubber, propylene rubber, NBR, SBR, and others. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/2791 The raw material segment in the recycled elastomers market is
Metallic Pigments Market Size, Growth Opportunity 2024 |Top Companies are BASF, …
As per the Global Market Insights, Global metallic pigments market size is projected to hit USD 2.3 billion in annual sales by 2024. Mentioned below are some of the integral factors expected to support developments in metallic pigments market share through 2024. Increasing awareness among people regarding the need to use sustainable, low carbon emission paints and coatings is a major factor supporting developments in metallic pigments market. Aluminum and copper
Pressure Sensitive Tapes and Labels Market Overview with Detailed Analysis, Comp …
The unprecedented growth pace of pressure sensitive tapes and labels market is rather evident from Distell’s recent move towards adoption of pressure sensitive labels, As per news sources, the South Africa based multinational brewing and beverages company- Distell, in April this year, announced partnering with MCC to furnish the re-launch of Esprit in the nation with a conversion from paper to pressure sensitive labels. Official sources claim that switch to
Cosmetic Contact Lenses Market Current Business Trends & Growth Opportunities 20 …
Having garnered a considerable remuneration potential over the recent years, cosmetic contact lenses market has registered its name in the billion dollar business across the overall polymers and advanced materials industry. Back in time, contact lenses were regarded as a way toward an enhanced quality of life without the need for glasses, and despite being regarded as a medical device, the product’s use has seen massive demand from the cosmetic

All 5 Releases


More Releases for PEGylated

PEGylated Proteins Market Key highlights of the industry 2025
Global PEGylated Proteins Market: Snapshot The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations
PEGylated Proteins Market Striking over 2024
Global PEGylated Proteins Market: Snapshot The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations
PEGylated Proteins Market to See Incredible Growth
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
Segment-level analysis On PEGylated Proteins Market
Global PEGylated Proteins Market was worth USD 690.6 million in 2016 and estimated to be growing at a CAGR of 10.50%, to reach USD 1.137 billion by 2021. The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins.
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
PEGylated Proteins Market Research Report 2016-2024
The PEGylated Proteins Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation.PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic